The Hippo pathway is controlled by Angiotensin II signaling and its reactivation induces apoptosis in podocytes

Cell Death and Disease

Volumn 5, Issue 11, 2014, Pages

  Wennmann, D O ^a   Vollenbroker B ^a   Eckart, A K ^a   Bonse, J ^a   Erdmann, F ^b   Wolters, D A ^c   Schenk, L K ^a   Schulze, U ^a   Kremerskothen, J ^a   Weide, T ^a   Pavenstadt H ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; G PROTEIN COUPLED RECEPTOR; LARGE TUMOR SUPPRESSOR KINASE; PROTEIN KINASE YES; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; HIPPO PROTEIN, HUMAN; LATS1 PROTEIN, HUMAN; PHOSPHOPROTEIN; PROTEIN SERINE THREONINE KINASE; SIGNAL TRANSDUCING ADAPTOR PROTEIN; YAP1 (YES-ASSOCIATED) PROTEIN, HUMAN;

ACTIN FILAMENT; APOPTOSIS; ARTICLE; BLOOD PRESSURE; CELL SURVIVAL; CONTROLLED STUDY; GLOMERULAR FILTRATION BARRIER; HIPPO PATHWAY; HOMEOSTASIS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; ORGAN SIZE; PODOCYTE; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; WATER HOMEOSTASIS; ANIMAL; ANTIBODY SPECIFICITY; CHEMISTRY; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; HEK293 CELL LINE; METABOLISM; PHOSPHORYLATION; PRIMARY CELL CULTURE; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; TRANSFORMED CELL LINE; TRANSGENIC MOUSE;

ACTIN CYTOSKELETON; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANGIOTENSIN II; ANIMALS; APOPTOSIS; CELL LINE, TRANSFORMED; CELL SURVIVAL; GENE EXPRESSION REGULATION; HEK293 CELLS; HOMEOSTASIS; HUMANS; MICE; MICE, TRANSGENIC; ORGAN SPECIFICITY; PHOSPHOPROTEINS; PHOSPHORYLATION; PODOCYTES; PRIMARY CELL CULTURE; PROTEIN TRANSPORT; PROTEIN-SERINE-THREONINE KINASES; RECEPTOR, ANGIOTENSIN, TYPE 1; SIGNAL TRANSDUCTION;

EID: 84927929184     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2014.476     Document Type: Article

References (48)

1. Dong J, Feldmann G, Huang J, Wu S, Zhang N, Comerford SA et al. Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell 2007; 130: 1120-1133.
2. Huang J, Wu S, Barrera J, Matthews K, Pan D. The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila Homolog of YAP. Cell 2005; 122: 421-434.
3. Hilman D, Gat U. The evolutionary history of YAP and the hippo/YAP pathway. Mol Biol Evol 2011; 28: 2403-2417.
4. Ikmi A, Gaertner B, Seidel C, Srivastava M, Zeitlinger J, Gibson MC. Molecular evolution of the yap/yorkie proto-oncogene and elucidation of its core transcriptional program. Mol Biol Evol 2014; 31: 1375-1390.
5. Zhao B, Wei X, Li W, Udan RS, Yang Q, Kim J et al. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev 2007; 21: 2747-2761.
6. Basu S, Totty NF, Irwin MS, Sudol M, Downward J. Akt phosphorylates the Yes-associated protein, YAP, to induce interaction with 14-3-3 and attenuation of p73-mediated apoptosis. Mol Cell 2003; 11: 11-23.
7. Zhao B, Kim J, Ye X, Lai ZC, Guan KL. Both TEAD-binding and WW domains are required for the growth stimulation and oncogenic transformation activity of yes-associated protein. Cancer Res 2009; 69: 1089-1098.
8. Miller E, Yang J, DeRan M, Wu C, Su AI, Bonamy GM et al. Identification of serum-derived sphingosine-1-phosphate as a small molecule regulator of YAP. Chem Biol 2012; 19: 955-962.
9. Mo JS, Yu FX, Gong R, Brown JH, Guan KL. Regulation of the Hippo-YAP pathway by protease-activated receptors (PARs). Genes Dev 2012; 26: 2138-2143.
10. Yu FX, Zhao B, Panupinthu N, Jewell JL, Lian I, Wang LH et al. Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling. Cell 2012; 150: 780-791.
11. de Gasparo M, Catt KJ, Inagami T, Wright JW, Unger T. International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 2000; 52: 415-472.
12. Zaman MA, Oparil S, Calhoun DA. Drugs targeting the renin-angiotensin-aldosterone system. Nat Rev Drug Discov 2002; 1: 621-636.
13. Sarafidis PA, Khosla N, Bakris GL. Antihypertensive therapy in the presence of proteinuria. Am J Kidney Dis 2007; 49: 12-26.
14. Wennmann DO, Hsu HH, Pavenstadt H. The renin-angiotensin-aldosterone system in podocytes. Semin Nephrol 2012; 32: 377-384.
15. Ahn S, Kim J, Hara MR, Ren XR, Lefkowitz RJ. {beta}-Arrestin-2 Mediates Anti-apoptotic Signaling through Regulation of BAD Phosphorylation. J Biol Chem 2009; 284: 8855-8865.
16. Sadoshima J, Qiu Z, Morgan JP, Izumo S. Angiotensin II and other hypertrophic stimuli mediated by G protein-coupled receptors activate tyrosine kinase, mitogen-activated protein kinase, and 90-kD S6 kinase in cardiac myocytes. The critical role of Ca(2+)-dependent signaling. Circ Res 1995; 76: 1-15.
17. Wei H, Ahn S, Shenoy SK, Karnik SS, Hunyady L, Luttrell LM et al. Independent beta-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signalregulated kinases 1 and 2. Proc Natl Acad Sci U S A 2003; 100: 10782-10787.
18. Nitschke R, Henger A, Ricken S, Gloy J, Muller V, Greger R et al. Angiotensin II increases the intracellular calcium activity in podocytes of the intact glomerulus. Kidney Int 2000; 57: 41-49.
19. Gloy J, Henger A, Fischer KG, Nitschke R, Mundel P, Bleich M et al. Angiotensin II depolarizes podocytes in the intact glomerulus of the Rat. J Clin Invest 1997; 99: 2772-2781.
20. Saleem MA, O'Hare MJ, Reiser J, Coward RJ, Inward CD, Farren T et al. A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression. J Am Soc Nephrol 2002; 13: 630-638.
21. Chan EH, Nousiainen M, Chalamalasetty RB, Schafer A, Nigg EA, Sillje HH. The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1. Oncogene 2005; 24: 2076-2086.
22. Dupont S, Morsut L, Aragona M, Enzo E, Giulitti S, Cordenonsi M et al. Role of YAP/TAZ in mechanotransduction. Nature 2011; 474: 179-183.
23. Low BC, Pan CQ, Shivashankar GV, Bershadsky A, Sudol M, Sheetz M. YAP/TAZ as mechanosensors and mechanotransducers in regulating organ size and tumor growth. FEBS Lett 2014; 588: 2663-2670.
24. Faul C, Asanuma K, Yanagida-Asanuma E, Kim K, Mundel P. Actin up: regulation of podocyte structure and function by components of the actin cytoskeleton. Trends Cell Biol 2007; 17: 428-437.
25. Visser S, Yang X. LATS tumor suppressor: a new governor of cellular homeostasis. Cell Cycle 2010; 9: 3892-3903.
26. Wennmann DO, Schmitz J, Wehr MC, Krahn MP, Koschmal N, Gromnitza S et al. Evolutionary and molecular facts link the WWC protein family to Hippo signaling. Mol Biol Evol 2014; 31: 1710-1723.
27. Cong EH, Bizet AA, Boyer O, Woerner S, Gribouval O, Filhol E et al. A Homozygous Missense Mutation in the Ciliary Gene TTC21B Causes Familial FSGS. J Am Soc Nephrol 2014; 25: 2435-2443.
28. Duning K, Schurek EM, Schluter M, Bayer M, Reinhardt HC, Schwab A et al. KIBRA modulates directional migration of podocytes. J Am Soc Nephrol 2008; 19: 1891-1903.
29. Yu FX, Luo J, Mo JS, Liu G, Kim YC, Meng Z et al. Mutant Gq/11 Promote Uveal Melanoma Tumorigenesis by Activating YAP. Cancer Cell 2014; 25: 822-830.
30. Wada K, Itoga K, Okano T, Yonemura S, Sasaki H. Hippo pathway regulation by cell morphology and stress fibers. Development 2011; 138: 3907-3914.
31. Feng X, Degese MS, Iglesias-Bartolome R, Vaque JP, Molinolo AA, Rodrigues M et al. Hippo-Independent Activation of YAP by the GNAQ Uveal Melanoma Oncogene through a Trio-Regulated Rho GTPase Signaling Circuitry. Cancer Cell 2014; 25: 831-845.
32. Yang X, Yu K, Hao Y, Li DM, Stewart R, Insogna KL et al. LATS1 tumour suppressor affects cytokinesis by inhibiting LIMK1. Nat Cell Biol 2004; 6: 609-617.
33. Aragona M, Panciera T, Manfrin A, Giulitti S, Michielin F, Elvassore N et al. A mechanical checkpoint controls multicellular growth through YAP/TAZ regulation by actin-processing factors. Cell 2013; 154: 1047-1059.
34. Campbell KN, Wong JS, Gupta R, Asanuma K, Sudol M, He JC et al. Yes-associated protein (YAP) promotes cell survival by inhibiting proapoptotic dendrin signaling. J Biol Chem 2013; 288: 17057-17062.
35. Kim YH, Goyal M, Kurnit D, Wharram B, Wiggins J, Holzman L et al. Podocyte depletion and glomerulosclerosis have a direct relationship in the PAN-treated rat. Kidney Int 2001; 60: 957-968.
36. Happé H, van der Wal AM, Leonhard WN, Kunnen SJ, Breuning MH, de Heer E et al. Altered Hippo signaling in polycystic kidney disease. J Pathol 2011; 224: 133-142.
37. Regenensi A, Scott RP, Gregorieff A, Bagherie-Lachidan M, Chung C, Lim DS et al. Yap-and Cdc42-dependent nephrogenesis and morphogenesis during mouse kidney development. PLOS Genet 2013; 9: e1003380.
38. Habbig S, Bartram MP, Müller RU, Schwarz R, Andriopoulos N, Chen S et al. NPHP4, a cilia-associated Protein, negatively regulates the Hippo pathway. J Cell Biol 2011; 193: 633-642.
39. Habbig S, Bartram MP, Sägmüller JG, Griessmann A, Franke M, Müller RU et al. The ciliopathy disease protein NPHP9 promotes nuclear delivery and activation of the oncogenic transcriptional regulator TAZ. Hum Mol Genet. 2012; 21: 5528-5538.
40. Hsu HH, Hoffmann S, Di Marco GS, Endlich N, Peter-Katalinić J, Weide T et al. Downregulation of the antioxidant protein peroxiredoxin 2 contributes to angiotensin II-mediated podocyte apoptosis. Kidney Int 2011; 80: 959-969.
41. Tharaux PL, Huber TB. How many ways can a podocyte die? Semin Nephrol 2012; 32: 394-404.
42. Schulze U, Vollenbroker B, Braun DA, Van LT, Granado D, Kremerskothen J et al. The Vac14-interaction Network Is Linked to Regulators of the Endolysosomal and Autophagic Pathway. Mol Cell Proteomics 2014; 13: 1397-1411.
43. Paramasivam M, Sarkeshik A, Yates JR III, Fernandes MJ, McCollum D. Angiomotin family proteins are novel activators of the LATS2 kinase tumor suppressor. Mol Biol Cell 2011; 22: 3725-3733.
44. Meerbrey KL, Hu G, Kessler JD, Roarty K, Li MZ, Fang JE et al. The pINDUCER lentiviral toolkit for inducible RNA interference in vitro and in vivo. Proc Natl Acad Sci USA 2011; 108: 3665-3670.
45. Boerries M, Grahammer F, Eiselein S, Buck M, Meyer C, Goedel M et al. Molecular fingerprinting of the podocyte reveals novel gene and protein regulatory networks. Kidney Int 2013; 83: 1052-1064.
46. Muzumdar MD, Tasic B, Miyamichi K, Li L, Luo L. A global double-fluorescent Cre reporter mouse. Genesis 2007; 45: 593-605.
47. Moeller MJ, Sanden SK, Soofi A, Wiggins RC, Holzman LB. Podocyte-specific expression of cre recombinase in transgenic mice. Genesis 2003; 35: 39-42.
48. Ilatovskaya DV, Palygin O, Chubinskiy-Nadezhdin V, Negulyaev YA, Ma R, Birnbaumer L et al. Angiotensin II has acute effects on TRPC6 channels in podocytes of freshly isolated glomeruli. Kidney Int 2014; 86: 506-514.